These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28133891)

  • 21. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melasma treatment with oral tranexamic acid and a novel adjuvant topical therapy.
    Cohen PR
    Cutis; 2018 Aug; 102(2):106. PubMed ID: 30235369
    [No Abstract]   [Full Text] [Related]  

  • 23. Tranexamic acid: an important adjuvant in the treatment of melasma.
    Tse TW; Hui E
    J Cosmet Dermatol; 2013 Mar; 12(1):57-66. PubMed ID: 23438143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
    Taraz M; Niknam S; Ehsani AH
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
    Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
    Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
    Cho HH; Choi M; Cho S; Lee JH
    J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Topical Use of Petroselinum Crispum (Parsley) Versus That of Hydroquinone Cream on Reduction of Epidermal Melasma: A Randomized Clinical Trial.
    Khosravan S; Alami A; Mohammadzadeh-Moghadam H; Ramezani V
    Holist Nurs Pract; 2017; 31(1):16-20. PubMed ID: 27902522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emerging importance of tranexamic acid in dermatology.
    Forbat E; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2020 Jun; 45(4):445-449. PubMed ID: 31663643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
    Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
    J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
    El Hadidi H; Mosaad R; Ragab N
    Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
    Monheit GD; Dreher F
    J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perilla frutescens leaves extract ameliorates ultraviolet radiation-induced extracellular matrix damage in human dermal fibroblasts and hairless mice skin.
    Bae JS; Han M; Shin HS; Kim MK; Shin CY; Lee DH; Chung JH
    J Ethnopharmacol; 2017 Jan; 195():334-342. PubMed ID: 27888134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What's New in Pigmentary Disorders.
    Zubair R; Lyons AB; Vellaichamy G; Peacock A; Hamzavi I
    Dermatol Clin; 2019 Apr; 37(2):175-181. PubMed ID: 30850040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous Pathology of Melasma and Its Clinical Implications.
    Kwon SH; Hwang YJ; Lee SK; Park KC
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of melasma using tranexamic acid: what's known and what's next.
    Sheu SL
    Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
    Grimes PE
    J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability and efficacy of a novel formulation in the treatment of melasma.
    Guevara IL; Werlinger KD; Pandya AG
    J Drugs Dermatol; 2010 Mar; 9(3):215-8. PubMed ID: 20232581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma.
    Gold MH; Biron J
    J Cosmet Dermatol; 2011 Sep; 10(3):189-96. PubMed ID: 21896130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.